Cite
HARVARD Citation
de Baat, E. et al. (2022). Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet. pp. 885-894. [Online].